Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events : nationwide cohort study. / Bretler, Ditte-Marie; Hansen, Peter Riis; Sørensen, Rikke; Lindhardsen, Jesper; Ahlehoff, Ole; Andersson, Charlotte; Abildstrøm, Steen Zabell; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar.

I: B M J, Bind 344, 2012, s. e1802.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Bretler, D-M, Hansen, PR, Sørensen, R, Lindhardsen, J, Ahlehoff, O, Andersson, C, Abildstrøm, SZ, Torp-Pedersen, C & Gislason, GH 2012, 'Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study', B M J, bind 344, s. e1802. https://doi.org/10.1136/bmj.e1802

APA

Bretler, D-M., Hansen, P. R., Sørensen, R., Lindhardsen, J., Ahlehoff, O., Andersson, C., Abildstrøm, S. Z., Torp-Pedersen, C., & Gislason, G. H. (2012). Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study. B M J, 344, e1802. https://doi.org/10.1136/bmj.e1802

Vancouver

Bretler D-M, Hansen PR, Sørensen R, Lindhardsen J, Ahlehoff O, Andersson C o.a. Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study. B M J. 2012;344:e1802. https://doi.org/10.1136/bmj.e1802

Author

Bretler, Ditte-Marie ; Hansen, Peter Riis ; Sørensen, Rikke ; Lindhardsen, Jesper ; Ahlehoff, Ole ; Andersson, Charlotte ; Abildstrøm, Steen Zabell ; Torp-Pedersen, Christian ; Gislason, Gunnar Hilmar. / Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events : nationwide cohort study. I: B M J. 2012 ; Bind 344. s. e1802.

Bibtex

@article{d49368196e34460b88956fa4f612836e,
title = "Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study",
abstract = "To assess the risk of adverse cardiovascular events in women who discontinue hormone replacement therapy after myocardial infarction compared with those who continue.",
author = "Ditte-Marie Bretler and Hansen, {Peter Riis} and Rikke S{\o}rensen and Jesper Lindhardsen and Ole Ahlehoff and Charlotte Andersson and Abildstr{\o}m, {Steen Zabell} and Christian Torp-Pedersen and Gislason, {Gunnar Hilmar}",
year = "2012",
doi = "10.1136/bmj.e1802",
language = "English",
volume = "344",
pages = "e1802",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",

}

RIS

TY - JOUR

T1 - Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events

T2 - nationwide cohort study

AU - Bretler, Ditte-Marie

AU - Hansen, Peter Riis

AU - Sørensen, Rikke

AU - Lindhardsen, Jesper

AU - Ahlehoff, Ole

AU - Andersson, Charlotte

AU - Abildstrøm, Steen Zabell

AU - Torp-Pedersen, Christian

AU - Gislason, Gunnar Hilmar

PY - 2012

Y1 - 2012

N2 - To assess the risk of adverse cardiovascular events in women who discontinue hormone replacement therapy after myocardial infarction compared with those who continue.

AB - To assess the risk of adverse cardiovascular events in women who discontinue hormone replacement therapy after myocardial infarction compared with those who continue.

U2 - 10.1136/bmj.e1802

DO - 10.1136/bmj.e1802

M3 - Journal article

VL - 344

SP - e1802

JO - The BMJ

JF - The BMJ

SN - 0959-8146

ER -

ID: 40155448